Abstract
Vascular endothelial growth factor (VEGF) is essential for many angiogenic processes both in normal and pathological conditions. However, the signaling pathways involved in VEGF-induced angiogenesis are incompletely understood. The protein kinase D1 (PKD1), a newly described calcium/calmodulin-dependent serine/threonine kinase, has been implicated in cell migration, proliferation and membrane trafficking. Increasing evidence suggests critical roles for PKD1-mediated signaling pathways in endothelial cells, particularly in the regulation of VEGF-induced angiogenesis. Recent studies show that class IIa histone deacetylases (HDACs) are PKD1 substrates and VEGF signal-responsive repressors of myocyte enhancer factor-2 (MEF2) transcriptional activation in endothelial cells. This review provides a guide to PKD1 signaling pathways and the direct downstream targets of PKD1 in VEGF signaling, and suggests important functions of PKD1 in angiogenesis.
Similar content being viewed by others
References
Abedi, H., Rozengurt, E., and Zachary, I. (1998). Rapid activation of the novel serine/threonine protein kinase, protein kinase D by phorbol esters, angiotensin II and PDGF-BB in vascular smooth muscle cells. FEBS Lett. 427, 209–212.
Auer, A., von Blume, J., Sturany, S., von Wichert, G., Van Lint, J., Vandenheede, J., Adler, G., and Seufferlein, T. (2005). Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling. Mol. Biol. Cell 16, 4375–4385.
Avkiran, M., Rowland, A.J., Cuello, F., and Haworth, R.S. (2008). Protein kinase d in the cardiovascular system: emerging roles in health and disease. Circ. Res. 102, 157–163.
Backs, J., Song, K., Bezprozvannaya, S., Chang, S., and Olson, E.N. (2006). CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116, 1853–1864.
Baron, C.L., and Malhotra, V. (2002). Role of diacylglycerol in PKD recruitment to the TGN and protein transport to the plasma membrane. Science 295, 325–328.
Benjamin, L.E., and Keshet, E. (1997). Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA 94, 8761–8766.
Benjamin, L.E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. (1999). Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 159–165.
Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389–395.
Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9, 653–660.
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435–439.
Carmeliet, P., Lampugnani, M.G., Moons, L., Breviario, F., Compernolle, V., Bono, F., Balconi, G., Spagnuolo, R., Oostuyse, B., Dewerchin, M.I et al. (1999). Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98, 147–157.
Chang, S., Young, B.D., Li, S., Qi, X., Richardson, J.A., and Olson, E.N. (2006). Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126, 321–334.
Chen, H., Chedotal, A., He, Z., Goodman, C.S., and Tessier-Lavigne, M. (1997). Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 19, 547–559.
Chiu, T., and Rozengurt, E. (2001)a. CCK2 (CCK(B)/gastrin) receptor mediates rapid protein kinase D (PKD) activation through a protein kinase C-dependent pathway. FEBS Lett. 489, 101–106.
Chiu, T., and Rozengurt, E. (2001)b. PKD in intestinal epithelial cells: rapid activation by phorbol esters, LPA, and angiotensin through PKC. Am. J. Physiol. 280, C929–942.
Chiu, T., Wu, S.S., Santiskulvong, C., Tangkijvanich, P., Yee, H.F., Jr., and Rozengurt, E. (2002). Vasopressin-mediated mitogenic signaling in intestinal epithelial cells. Am. J. Physiol. 282, C434–450.
Claesson-Welsh, L. (2003). Signal transduction by vascular endothelial growth factor receptors. Biochem. Soc. Trans. 31, 20–24.
Eliceiri, B.P., Paul, R., Schwartzberg, P.L., Hood, J.D., Leng, J., and Cheresh, D.A. (1999). Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4, 915–924.
Ferrara, N. (2002). VEGF and the quest for tumour angiogenesis factors. Nat. Rev. 2, 795–803.
Ferrara, N., and Alitalo, K. (1999). Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5, 1359–1364.
Ferrara, N., and Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. Endocrine Rev. 18, 4–25.
Ferrara, N., Gerber, H.P., and LeCouter, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669–676.
Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27–31.
Fong, G.H., Rossant, J., Gertsenstein, M., and Breitman, M.L. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66–70.
Gerber, H.P., Dixit, V., and Ferrara, N. (1998)a. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 273, 13313–13316.
Gerber, H.P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B.A., Dixit, V., and Ferrara, N. (1998)b. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273, 30336–30343.
Gille, H., Kowalski, J., Li, B., LeCouter, J., Moffat, B., Zioncheck, T.F., Pelletier, N., and Ferrara, N. (2001). Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J. Biol. Chem. 276, 3222–3230.
Guo, D., Jia, Q., Song, H.Y., Warren, R.S., and Donner, D.B. (1995). Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270, 6729–6733.
Ha, C.H., Jhun, B.S., Kao, H.Y., and Jin, Z.G. (2008)a. VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 28, 1782–1788.
Ha, C.H., Wang, W., Jhun, B.S., Wong, C., Hausser, A., Pfizenmaier, K., McKinsey, T.A., Olson, E.N., and Jin, Z.G. (2008)b. Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis. J. Biol. Chem. 283, 14590–14599.
Hanks, S.K. (2003). Genomic analysis of the eukaryotic protein kinase superfamily: a perspective. Genome Biol. 4, 111.
Hao, Q., Wang, L., Zhao, Z.J., and Tang, H. (2009). Identification of protein kinase D2 as a pivotal regulator of endothelial cell proliferation, migration, and angiogenesis. J. Biol. Chem. 284, 799–806.
Hausser, A., Link, G., Bamberg, L., Burzlaff, A., Lutz, S., Pfizenmaier, K., and Johannes, F.J. (2002). Structural requirements for localization and activation of protein kinase C mu (PKC mu) at the Golgi compartment. J. Cell Biol. 156, 65–74.
Haworth, R.S., Goss, M.W., Rozengurt, E., and Avkiran, M. (2000). Expression and activity of protein kinase D/protein kinase C mu in myocardium: evidence for alpha1-adrenergic receptor- and protein kinase C-mediated regulation. J. Mol. Cell. Cardiol. 32, 1013–1023.
Haworth, R.S., Cuello, F., Herron, T.J., Franzen, G., Kentish, J.C., Gautel, M., and Avkiran, M. (2004). Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ. Res. 95, 1091–1099.
Hayashi, A., Seki, N., Hattori, A., Kozuma, S., and Saito, T. (1999). PKCnu, a new member of the protein kinase C family, composes a fourth subfamily with PKCmu. Biochim. Biophys. Acta 1450, 99–106.
Houck, K.A., Ferrara, N., Winer, J., Cachianes, G., Li, B., and Leung, D.W. (1991). The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. (Baltimore, Md 5, 1806–1814.
Iglesias, T., and Rozengurt, E. (1998). Protein kinase D activation by mutations within its pleckstrin homology domain. J. Biol. Chem. 273, 410–416.
Iglesias, T., Matthews, S., and Rozengurt, E. (1998)a. Dissimilar phorbol ester binding properties of the individual cysteine-rich motifs of protein kinase D. FEBS Lett. 437, 19–23.
Iglesias, T., Waldron, R.T., and Rozengurt, E. (1998)b. Identification of in vivo phosphorylation sites required for protein kinase D activation. J. Biol. Chem. 273, 27662–27667.
Jamora, C., Yamanouye, N., Van Lint, J., Laudenslager, J., Vandenheede, J.R., Faulkner, D.J., and Malhotra, V. (1999). Gbetagamma-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell 98, 59–68.
Johannes, F.J., Prestle, J., Eis, S., Oberhagemann, P., and Pfizenmaier, K. (1994). PKCu is a novel, atypical member of the protein kinase C family. J. Biol. Chem. 269, 6140–6148.
Kolodkin, A.L., Levengood, D.V., Rowe, E.G., Tai, Y.T., Giger, R.J., and Ginty, D.D. (1997). Neuropilin is a semaphorin III receptor. Cell 90, 753–762.
Kunkel, M.T., Toker, A., Tsien, R.Y., and Newton, A.C. (2007). Calcium-dependent regulation of protein kinase D revealed by a genetically encoded kinase activity reporter. J. Biol. Chem. 282, 6733–6742.
Liljedahl, M., Maeda, Y., Colanzi, A., Ayala, I., Van Lint, J., and Malhotra, V. (2001). Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network. Cell 104, 409–420.
Lin, Q., Lu, J., Yanagisawa, H., Webb, R., Lyons, G.E., Richardson, J.A., and Olson, E.N. (1998). Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125, 4565–4574.
Lint, J.V., Rykx, A., Vantus, T., and Vandenheede, J.R. (2002). Getting to know protein kinase D. Int. J. Biochem. Cell Biol. 34, 577–581.
Matthews, S.A., Pettit, G.R., and Rozengurt, E. (1997). Bryostatin 1 induces biphasic activation of protein kinase D in intact cells. J. Biol. Chem. 272, 20245–20250.
Matthews, S.A., Rozengurt, E., and Cantrell, D. (1999). Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/Protein kinase Cmu. J. Biol. Chem. 274, 26543–26549.
Matthews, S.A., Iglesias, T., Rozengurt, E., and Cantrell, D. (2000)a. Spatial and temporal regulation of protein kinase D (PKD). EMBO J. 19, 2935–2945.
Matthews, S.A., Rozengurt, E., and Cantrell, D. (2000)b. Protein kinase D. A selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J. Exp. Med. 191, 2075–2082.
McKinsey, T.A., and Olson, E.N. (2005). Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J. Clin. Invest. 115, 538–546.
Mellor, H., and Parker, P.J. (1998). The extended protein kinase C superfamily. Biochem. J. 332, 281–292.
Meyer, M., Clauss, M., Lepple-Wienhues, A., Waltenberger, J., Augustin, H.G., Ziche, M., Lanz, C., Buttner, M., Rziha, H.J., and Dehio, C. (1999). A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J. 18, 363–374.
Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9–22.
Newton, A.C. (1997). Regulation of protein kinase C. Curr. Opin. Cell Biol. 9, 161–167.
Qin, L., Zeng, H., and Zhao, D. (2006). Requirement of protein kinase D tyrosine phosphorylation for VEGF-A165-induced angiogenesis through its interaction and regulation of phospholipase Cgamma phosphorylation. J. Biol. Chem. 281, 32550–32558.
Rey, O., and Rozengurt, E. (2001). Protein kinase D interacts with Golgi via its cysteine-rich domain. Biochem. Biophys. Res. Commun. 287, 21–26.
Rey, O., Young, S.H., Cantrell, D., and Rozengurt, E. (2001). Rapid protein kinase D translocation in response to G protein-coupled receptor activation. Dependence on protein kinase C. J. Biol. Chem. 276, 32616–32626.
Rey, O., Yuan, J., Young, S.H., and Rozengurt, E. (2003). Protein kinase C nu/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G proteincoupled receptor agonists. J. Biol. Chem. 278, 23773–23785.
Rey, O., Reeve, J.R., Jr., Zhukova, E., Sinnett-Smith, J., and Rozengurt, E. (2004). G protein-coupled receptor-mediated phosphorylation of the activation loop of protein kinase D: dependence on plasma membrane translocation and protein kinase Cepsilon. J. Biol. Chem. 279, 34361–34372.
Robinson, C.J., and Stringer, S.E. (2001). The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114, 853–865.
Rozengurt, E., Rey, O., and Waldron, R.T. (2005). Protein kinase D signaling. J. Biol. Chem. 280, 13205–13208.
Sakurai, Y., Ohgimoto, K., Kataoka, Y., Yoshida, N., and Shibuya, M. (2005). Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc. Natl. Acad. Sci. USA 102, 1076–1081.
Shalaby, F., Rossant, J., Yamaguchi, T.P., Gertsenstein, M., Wu, X.F., Breitman, M.L., and Schuh, A.C. (1995). Failure of bloodisland formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62–66.
Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., and Sato, M. (1990). Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5, 519–524.
Sidorenko, S.P., Law, C.L., Klaus, S.J., Chandran, K.A., Takata, M., Kurosaki, T., and Clark, E.A. (1996). Protein kinase C mu (PKC mu) associates with the B cell antigen receptor complex and regulates lymphocyte signaling. Immunity 5, 353–363.
Stafford, M.J., Watson, S.P., and Pears, C.J. (2003). PKD: a new protein kinase C-dependent pathway in platelets. Blood 101, 1392–1399.
Stalmans, I., Ng, Y.S., Rohan, R., Fruttiger, M., Bouche, A., Yuce, A., Fujisawa, H., Hermans, B., Shani, M., Jansen, S.I. et al. (2002). Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109, 327–336.
Storz, P., and Toker, A. (2003). Protein kinase D mediates a stressinduced NF-kappaB activation and survival pathway. EMBO J. 22, 109–120.
Takahashi, T., Ueno, H., and Shibuya, M. (1999). VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEKMAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18, 2221–2230.
Takahashi, T., Yamaguchi, S., Chida, K., and Shibuya, M. (2001). A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J. 20, 2768–2778.
Terman, B.I., Carrion, M.E., Kovacs, E., Rasmussen, B.A., Eddy, R.L., and Shows, T.B. (1991). Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6, 1677–1683.
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J.C., and Abraham, J.A. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947–11954.
Valverde, A.M., Sinnett-Smith, J., Van Lint, J., and Rozengurt, E. (1994). Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc. Natl. Acad. Sci. USA 91, 8572–8576.
Van Lint, J.V., Sinnett-Smith, J., and Rozengurt, E. (1995). Expression and characterization of PKD, a phorbol ester and diacylglycerol-stimulated serine protein kinase. J. Biol. Chem. 270, 1455–1461.
Waldron, R.T., Iglesias, T., and Rozengurt, E. (1999). The pleckstrin homology domain of protein kinase D interacts preferentially with the eta isoform of protein kinase C. J. Biol. Chem. 274, 9224–9230.
Waldron, R.T., Rey, O., Iglesias, T., Tugal, T., Cantrell, D., and Rozengurt, E. (2001). Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. J. Biol. Chem. 276, 32606–32615.
Waldron, R.T., and Rozengurt, E. (2003). Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. J. Biol. Chem. 278, 154–163.
Wang, S., Li, X., Parra, M., Verdin, E., Bassel-Duby, R., Olson, E.N. (2008). Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc. Natl. Acad. Sci. USA 108, 7738–7743.
Wise, L.M., Veikkola, T., Mercer, A.A., Savory, L.J., Fleming, S.B., Caesar, C., Vitali, A., Makinen, T., Alitalo, K., and Stacker, S.A. (1999). Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc. Natl. Acad. Sci. USA 96, 3071–3076.
Wong, C., and Jin, Z.G. (2005). Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. J. Biol. Chem. 280, 33262–33269.
Xu, X., Ha, C.H., Wong, C., Wang, W., Hausser, A., Pfizenmaier, K., Olson, E.N., McKinsey, T.A., and Jin, Z.G. (2007). Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy. Arterioscler. Thromb. Vasc. Biol. 27, 2355–2362.
Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J., and Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242–248.
Yeaman, C., Ayala, M.I., Wright, J.R., Bard, F., Bossard, C., Ang, A., Maeda, Y., Seufferlein, T., Mellman, I., Nelson, W.J.I et al. (2004). Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network. Nat. Cell Biol. 6, 106–112.
Youn, H.D., and Liu, J.O. (2000). Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity 13, 85–94.
Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., and Jain, R.K. (1996). Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. USA 93, 14765–14770.
Zachary, I. (2003). VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans. 31, 1171–1177.
Zhang, C.L., McKinsey, T.A., Chang, S., Antos, C.L., Hill, J.A., and Olson, E.N. (2002). Class II histone deacetylases act as signalresponsive repressors of cardiac hypertrophy. Cell 110, 479–488.
Zhukova, E., Sinnett-Smith, J., and Rozengurt, E. (2001). Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells. J. Biol. Chem. 276, 40298–40305.
Zugaza, J.L., Sinnett-Smith, J., Van Lint, J., and Rozengurt, E. (1996). Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. EMBO J. 15, 6220–6230.
Zugaza, J.L., Waldron, R.T., Sinnett-Smith, J., and Rozengurt, E. (1997). Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway. J. Biol. Chem. 272, 23952–23960.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ha, C.H., Jin, Z.G. Protein kinase D1, a new molecular player in VEGF signaling and angiogenesis. Mol Cells 28, 1–5 (2009). https://doi.org/10.1007/s10059-009-0109-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-009-0109-9